Vergoeding 2018-2022 voor ATC-subgroep G04CA : Alfa-blokkers
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| G04CA01 Alfuzosine (Xatral ®) | 899.210 | 911.850 | 847.420 | 787.350 | 782.150 |
| G04CA02 Tamsulosine (Omnic ®) | 2.013.400 | 2.018.700 | 2.070.600 | 1.916.200 | 1.940.300 |
| G04CA03 Terazosine (Hytrin ®) | 57.132 | 57.170 | 55.417 | 17.393 | 14.358 |
| G04CA04 Silodosine (Silodyx ®) | 875.920 | 934.020 | 910.740 | 858.500 | 910.450 |
| G04CA52 Tamsulosine met dutasteride (Combodart ®) | 9.043.500 | 9.084.200 | 7.292.700 | 3.223.300 | 2.258.300 |
| G04CA53 Tamsulosine met solifenacine (Vesomni ®) | 2.961.600 | 3.333.500 | 3.543.400 | 3.862.800 | 4.331.100 |
| Totaal | 15.850.762 | 16.339.440 | 14.720.277 | 10.665.543 | 10.236.658 |